$APVO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aptevo Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aptevo Therapeutics Inc.. Get notifications about new insider transactions in Aptevo Therapeutics Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.89 | 30,000 | 26,601 | 959,521 | 929.5 K to 959.5 K (+3.23 %) |
| Jul 19 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.90 | 26,460 | 23,740 | 929,521 | 903.1 K to 929.5 K (+2.93 %) |
| Jul 18 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.87 | 14,404 | 12,596 | 903,061 | 888.7 K to 903.1 K (+1.62 %) |
| Jul 18 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.87 | 19,136 | 16,704 | 888,657 | 869.5 K to 888.7 K (+2.20 %) |
| Jul 16 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.85 | 11,375 | 9,662 | 869,521 | 858.1 K to 869.5 K (+1.33 %) |
| Jul 12 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Buy | P | 0.85 | 14,691 | 12,454 | 858,146 | 843.5 K to 858.1 K (+1.74 %) |
| Jul 11 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Buy | P | 0.85 | 18,919 | 16,058 | 843,455 | 824.5 K to 843.5 K (+2.29 %) |
| Jun 25 2019 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Board of Directors | Buy | P | 0.90 | 16,667 | 15,000 | 109,351 | 92.7 K to 109.4 K (+17.98 %) |
| Jun 14 2019 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | P | 0.88 | 50,000 | 44,000 | 293,603 | 243.6 K to 293.6 K (+20.53 %) |
| Jun 11 2019 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Board of Directors | Buy | P | 0.85 | 10,000 | 8,481 | 10,000 | 0 to 10 K |
| Jun 07 2019 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Board of Directors | Buy | P | 0.78 | 50,000 | 39,000 | 50,000 | 0 to 50 K |
| Jun 07 2019 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | Senior VP, Operatio ... | Buy | P | 0.73 | 20,000 | 14,600 | 50,000 | 30 K to 50 K (+66.67 %) |
| Jun 04 2019 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
| Jun 04 2019 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
| Jun 04 2019 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
| Jun 04 2019 | APVO | Aptevo Therapeutic ... | Grant Grady III | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
| Jun 04 2019 | APVO | Aptevo Therapeutic ... | Niederhuber John | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
| Jun 04 2019 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Board of Directors | Option Exercise | A | 0.73 | 25,000 | 18,125 | 25,000 | |
| May 21 2019 | APVO | Aptevo Therapeutic ... | Grant Grady III | Board of Directors | Buy | P | 0.80 | 10,000 | 7,970 | 10,000 | 0 to 10 K |
| May 20 2019 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | P | 0.81 | 30,000 | 24,300 | 243,603 | 213.6 K to 243.6 K (+14.04 %) |
| May 14 2019 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | P | 0.78 | 10,000 | 7,800 | 213,603 | 203.6 K to 213.6 K (+4.91 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 1.52 | 151,600 | 230,432 | 151,600 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 16,269 | 0 | 0 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 1.57 | 4,823 | 7,572 | 216,183 | 221 K to 216.2 K (-2.18 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 16,269 | 0 | 221,006 | 204.7 K to 221 K (+7.95 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Option Exercise | M | 0.00 | 6,787 | 0 | 0 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Payment of Exercise | F | 1.57 | 2,012 | 3,159 | 80,527 | 82.5 K to 80.5 K (-2.44 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Buy | M | 0.00 | 6,787 | 0 | 82,539 | 75.8 K to 82.5 K (+8.96 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP Operations, CMO | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | M | 0.00 | 7,318 | 0 | 0 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Payment of Exercise | F | 1.57 | 2,170 | 3,407 | 75,024 | 77.2 K to 75 K (-2.81 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Buy | M | 0.00 | 7,318 | 0 | 77,194 | 69.9 K to 77.2 K (+10.47 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,138 | 0 | 0 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.57 | 2,710 | 4,255 | 109,583 | 112.3 K to 109.6 K (-2.41 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,138 | 0 | 112,293 | 103.2 K to 112.3 K (+8.86 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Adelman Michael | SVP, Commercial Ope ... | Option Exercise | M | 0.00 | 7,318 | 0 | 0 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Adelman Michael | SVP, Commercial Ope ... | Option Exercise | A | 1.52 | 67,400 | 102,448 | 67,400 | |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Adelman Michael | SVP, Commercial Ope ... | Payment of Exercise | F | 1.57 | 2,395 | 3,760 | 70,426 | 72.8 K to 70.4 K (-3.29 %) |
| Mar 04 2019 | APVO | Aptevo Therapeutic ... | Adelman Michael | SVP, Commercial Ope ... | Buy | M | 0.00 | 7,318 | 0 | 72,821 | 65.5 K to 72.8 K (+11.17 %) |
| Dec 07 2018 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | SVP Operations | Buy | P | 2.37 | 5,000 | 11,850 | 30,000 | 25 K to 30 K (+20.00 %) |
| Dec 06 2018 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | P | 2.38 | 10,000 | 23,800 | 203,603 | 193.6 K to 203.6 K (+5.17 %) |
| Aug 13 2018 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Option Exercise | M | 0.00 | 1,630 | 0 | 6,787 | |
| Aug 13 2018 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Option Exercise | M | 0.00 | 1,630 | 0 | 6,787 | |
| Aug 13 2018 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Payment of Exercise | F | 4.50 | 383 | 1,724 | 75,752 | 76.1 K to 75.8 K (-0.50 %) |
| Aug 13 2018 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Payment of Exercise | F | 4.50 | 383 | 1,724 | 75,752 | 76.1 K to 75.8 K (-0.50 %) |
| Aug 13 2018 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Buy | M | 0.00 | 1,630 | 0 | 76,135 | 74.5 K to 76.1 K (+2.19 %) |
| Aug 13 2018 | APVO | Aptevo Therapeutic ... | Mitchell Shawnte | SVP, GC and Corpora ... | Buy | M | 0.00 | 1,630 | 0 | 76,135 | 74.5 K to 76.1 K (+2.19 %) |
| Jun 04 2018 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| Jun 04 2018 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| Jun 04 2018 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| Jun 04 2018 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| Jun 04 2018 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| Jun 04 2018 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 5.49 | 25,000 | 137,250 | 25,000 | |
| May 23 2018 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | M | 0.00 | 35,644 | 0 | 0 | |
| May 23 2018 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Payment of Exercise | F | 5.61 | 8,373 | 46,973 | 193,603 | 202 K to 193.6 K (-4.15 %) |
| May 23 2018 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | M | 0.00 | 35,644 | 0 | 201,976 | 166.3 K to 202 K (+21.43 %) |
| Mar 21 2018 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | S | 2.93 | 100,000 | 293,000 | 166,332 | 66.3 K to 166.3 K (+150.76 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 3.13 | 151,600 | 474,508 | 151,600 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,892 | 0 | 16,269 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | A | 3.13 | 67,400 | 210,962 | 67,400 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 13,892 | 0 | 204,737 | 190.8 K to 204.7 K (+7.28 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | Senior VP, Operatio ... | Option Exercise | A | 3.13 | 67,400 | 210,962 | 67,400 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 6,747 | 0 | 7,318 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 3.13 | 67,400 | 210,962 | 67,400 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 3.13 | 1,583 | 4,955 | 69,876 | 71.5 K to 69.9 K (-2.22 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 6,747 | 0 | 71,459 | 64.7 K to 71.5 K (+10.43 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,728 | 0 | 9,138 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 3.13 | 67,400 | 210,962 | 67,400 | |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 3.13 | 2,282 | 7,143 | 103,155 | 105.4 K to 103.2 K (-2.16 %) |
| Mar 13 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,728 | 0 | 105,437 | 95.7 K to 105.4 K (+10.16 %) |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,320 | 0 | 14,065 | |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 3.04 | 1,717 | 5,220 | 64,712 | 66.4 K to 64.7 K (-2.58 %) |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,320 | 0 | 66,429 | 59.1 K to 66.4 K (+12.38 %) |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,140 | 0 | 18,866 | |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,140 | 0 | 95,709 | 86.6 K to 95.7 K (+10.56 %) |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 16,269 | 0 | 30,161 | |
| Mar 05 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 16,269 | 0 | 190,845 | 174.6 K to 190.8 K (+9.32 %) |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 27,381 | 0 | 46,430 | |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 27,381 | 0 | 174,576 | 147.2 K to 174.6 K (+18.60 %) |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 18,136 | 0 | 28,006 | |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 18,136 | 0 | 86,569 | 68.4 K to 86.6 K (+26.50 %) |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 25,340 | 0 | 21,385 | |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 3.24 | 7,514 | 24,345 | 59,109 | 66.6 K to 59.1 K (-11.28 %) |
| Feb 06 2018 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 25,340 | 0 | 66,623 | 41.3 K to 66.6 K (+61.38 %) |
| Dec 08 2017 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | Senior VP, Operatio ... | Buy | P | 2.76 | 25,000 | 69,000 | 25,000 | 0 to 25 K |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 78,123 | 0 | 73,811 | |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 78,123 | 0 | 147,195 | 69.1 K to 147.2 K (+113.10 %) |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 38,093 | 0 | 46,142 | |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.83 | 10,076 | 18,439 | 68,433 | 78.5 K to 68.4 K (-12.83 %) |
| Aug 03 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 38,093 | 0 | 78,509 | 40.4 K to 78.5 K (+94.25 %) |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 2.15 | 75,800 | 162,970 | 75,800 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | A | 2.15 | 33,700 | 72,455 | 33,700 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | Senior VP, Operatio ... | Option Exercise | A | 2.15 | 33,700 | 72,455 | 33,700 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 2.15 | 33,700 | 72,455 | 33,700 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 2.15 | 33,700 | 72,455 | 33,700 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
| Jun 01 2017 | APVO | Aptevo Therapeutic ... | Abdun-Nabi Daniel | Director | Option Exercise | A | 2.15 | 12,500 | 26,875 | 12,500 | |
| May 23 2017 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | M | 0.00 | 17,828 | 0 | 35,644 | |
| May 23 2017 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | M | 0.00 | 35,643 | 0 | 53,472 | |
| May 23 2017 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | M | 0.00 | 17,828 | 0 | 66,332 | 48.5 K to 66.3 K (+36.76 %) |
| May 23 2017 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Buy | M | 0.00 | 35,643 | 0 | 48,504 | 12.9 K to 48.5 K (+277.14 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 14,506 | 0 | 84,235 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,727 | 0 | 98,741 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,140 | 0 | 108,468 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.78 | 3,837 | 6,830 | 40,416 | 44.3 K to 40.4 K (-8.67 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 14,506 | 0 | 44,253 | 29.7 K to 44.3 K (+48.76 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.80 | 2,573 | 4,631 | 29,747 | 32.3 K to 29.7 K (-7.96 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,727 | 0 | 32,320 | 22.6 K to 32.3 K (+43.05 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 2.02 | 2,148 | 4,339 | 22,593 | 24.7 K to 22.6 K (-8.68 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,140 | 0 | 25,011 | 15.9 K to 25 K (+57.59 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 18,863 | 0 | 46,725 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 6,746 | 0 | 65,588 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,320 | 0 | 72,334 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.78 | 4,990 | 8,882 | 41,284 | 46.3 K to 41.3 K (-10.78 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 18,863 | 0 | 46,274 | 27.4 K to 46.3 K (+68.82 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.78 | 1,785 | 3,177 | 27,411 | 29.2 K to 27.4 K (-6.11 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 6,746 | 0 | 29,196 | 22.5 K to 29.2 K (+30.05 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 2.02 | 1,936 | 3,911 | 22,450 | 24.4 K to 22.5 K (-7.94 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,320 | 0 | 24,386 | 17.1 K to 24.4 K (+42.89 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 24,836 | 0 | 151,934 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,902 | 0 | 176,770 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 16,269 | 0 | 190,672 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 1.78 | 6,570 | 11,695 | 69,072 | 75.6 K to 69.1 K (-8.69 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 24,836 | 0 | 75,642 | 50.8 K to 75.6 K (+48.88 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 1.80 | 3,678 | 6,620 | 50,806 | 54.5 K to 50.8 K (-6.75 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 13,902 | 0 | 54,484 | 40.6 K to 54.5 K (+34.26 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 2.02 | 5,312 | 10,730 | 40,582 | 45.9 K to 40.6 K (-11.57 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 16,269 | 0 | 45,894 | 29.6 K to 45.9 K (+54.92 %) |
| Feb 27 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | A | 1.96 | 33,700 | 66,052 | 236,580 | |
| Feb 27 2017 | APVO | Aptevo Therapeutic ... | Maddux Randy Joe | Senior VP, Operatio ... | Option Exercise | A | 1.96 | 33,700 | 66,052 | 108,700 | |
| Feb 27 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | A | 1.96 | 33,700 | 66,052 | 142,232 | |
| Feb 27 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | A | 1.96 | 33,700 | 66,052 | 156,339 | |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 27,381 | 0 | 206,941 | |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 27,381 | 0 | 29,625 | 2.2 K to 29.6 K (+1,220.19 %) |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 25,340 | 0 | 79,654 | |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.92 | 8,274 | 15,886 | 17,066 | 25.3 K to 17.1 K (-32.65 %) |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 25,340 | 0 | 25,340 | 0 to 25.3 K |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 18,135 | 0 | 117,608 | |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.92 | 5,922 | 11,370 | 15,871 | 21.8 K to 15.9 K (-27.17 %) |
| Feb 08 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 18,135 | 0 | 21,793 | 3.7 K to 21.8 K (+495.76 %) |
| Aug 05 2016 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | A | 0.00 | 78,124 | 0 | 78,124 | |
| Aug 05 2016 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | A | 0.00 | 54,762 | 0 | 54,762 |